Centre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Department of Biology, University of Nairobi, Nairobi, Kenya.
Front Cell Infect Microbiol. 2024 Nov 13;14:1468866. doi: 10.3389/fcimb.2024.1468866. eCollection 2024.
Although typhoid fever has largely been eliminated in high-income countries, it remains a major global public health concern especially among low- and middle-income countries. The causative agent, serovar Typhi ( Typhi), is a human restricted pathogen with a limited capacity to replicate outside the human host. Human carriers, 90% of whom have gallstones in their gallbladder, continue to shed the pathogen for an ill-defined period of time after treatment. The genetic mechanisms involved in establishing the carrier state are poorly understood, but . Typhi is thought to undergo specific genetic changes within the gallbladder as an adaptive mechanism. In the current study, we aimed to identify the genetic differences in longitudinal clinical . Typhi isolates from asymptomatic carriers with gallstones in a typhoid endemic setting in Nairobi, Kenya. Whole-genome sequences were analyzed from 22 . Typhi isolates, 20 from stool samples, and 2 from blood samples, all genotype 4.3.1 (H58). Out of this, 19 strains were from four patients also diagnosed with gallstones, of whom three had typhoid symptoms and continued to shed . Typhi after treatment. All isolates had point mutations in the quinolone resistance-determining region (QRDR), and only sub-lineage 4.3.1.2.EA3 encoded multidrug resistance genes. There was no variation in antimicrobial resistance patterns among strains from the same patient/household. Non-multidrug resistant (MDR) isolates formed significantly stronger biofilms than the MDR isolates, p<0.001. A point mutation within the gene ( A383T) was observed in strains isolated after clinical resolution from patients living in 75% of the households. For missense mutations in Vi capsular polysaccharide genes, P263S was also observed in 18% of the isolates. This study provides insights into the role of typhoid carriage, biofilm formation, AMR genes, and genetic variations in Typhi during asymptomatic carriage.
尽管伤寒在高收入国家已基本消除,但它仍是一个重大的全球公共卫生关注点,特别是在中低收入国家。病原体伤寒血清型(Typhi)是一种人类受限病原体,其在人体宿主外的复制能力有限。人类携带者中有 90%的人胆囊中有胆结石,在经过治疗后仍会在一段时间内继续排出病原体。建立携带者状态的遗传机制尚不清楚,但人们认为 Typhi 会在胆囊内发生特定的遗传变化,作为一种适应机制。在本研究中,我们旨在确定肯尼亚内罗毕伤寒流行地区有胆结石的无症状携带者的纵向临床 Typhi 分离株的遗传差异。对 22 株 Typhi 分离株的全基因组序列进行了分析,其中 20 株来自粪便样本,2 株来自血液样本,均为基因型 4.3.1(H58)。其中 19 株来自 4 位同时被诊断患有胆结石的患者,其中 3 位有伤寒症状,并在治疗后继续排出 Typhi。所有分离株的喹诺酮耐药决定区(QRDR)均有单点突变,只有亚系 4.3.1.2.EA3 编码多药耐药基因。来自同一患者/家庭的菌株之间的抗生素耐药模式没有差异。非多药耐药(MDR)分离株形成的生物膜明显强于 MDR 分离株,p<0.001。在从居住在 75%家庭的患者中分离出临床缓解后的菌株中观察到基因(A383T)内的一个点突变。在 Vi 荚膜多糖基因的错义突变中,也观察到 18%的分离株存在 P263S。本研究提供了有关伤寒带菌、生物膜形成、AMR 基因和无症状带菌期间 Typhi 遗传变异作用的见解。